A 5117: Prohibits substitution of prescribed epilepsy medication without notification and written consent of physician and patient; requires prescription to include notation of epilepsy diagnosis.
Latest action, July 13, 2017: Introduced in the Assembly, Referred to Assembly Health and Senior Services Committee